Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *pathogen protein synthesis machinery* encompasses the ribosome and the complete set of translation factors in pathogenic microorganisms (bacteria, viruses). The ribosome is a complex molecular machine composed of ribosomal RNA and proteins that decodes messenger RNA (mRNA) and catalyzes the formation of peptide bonds between amino acids, thus building proteins. This process is essential for the viability and replication of pathogenic cells. Numerous clinically important antibiotics specifically target different aspects of this machinery, including tRNA binding, peptide bond formation, and subunit assembly. Due to its fundamental and conserved role, it remains a highly validated and exploited target for anti-infective drugs[3][6][7].
Inhibition of aminoacyl-tRNA binding (e.g., tetracyclines block the A site) - Inhibition of peptide bond formation (e.g., chloramphenicol inhibits peptidyl transferase activity) - Interference with ribosomal subunit movement (e.g., macrolides stall ribosomes) - Blocking initiation or elongation by binding essential factors or sites on the ribosome[1][3][6]
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen Protein Synthesis Machinery.